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Background: Studies of lymphatic vessels were limited by the lack of specific markers. Recently, they 
have become possible due to the release of new D2-40 antibody, a selective marker for lymphatic 
endothelium. The aim of our study was to compare neoplastic invasion in lymphatic and blood vessels 
detected in hematoxylin and eosin (H&E) and immunohistochemistry-stained sections. Methodology: 
A total of 123 cases of invasive mammary carcinomas were studied and sorted out into three subgroups 
according to axillary staging (macrometastasis, micrometastasis and lymph node negative). Lymphatic 
vessel invasion (LVI) and blood vessel invasion (BVI) were initially evaluated in histological H&E and 
immunohistochemistry-stained sequential sections. Lymphatic and blood vessel invasions were assessed 
by immunohistochemistry, employing D2-40 and CD31 antibodies, respectively. LVI and BVI were 
related to size, type, histologic grade of primary tumors, and the presence of metastasis. Results: LVI was 
detected through H&E staining procedure in 17/123 cases (13.8%), and through immunohistochemistry 
procedure in 35/123 cases (28.5%) (kappa = 0.433). BVI was detected through H&E in 5/123 cases 
(4.1%), and through immunohistochemistry in 19/123 cases (15.4%) (kappa = 0.198). LVI and BVI 
were positively related to higher histologic grade of primary tumors (p < 0.05). LVI was also positively 
related to the presence of macrometastasis. Conclusion: The detection of lymphatic and blood vessel 
invasions through immunohistochemistry employing D2-40 and CD31 was higher than the detection 
through H&E, and it was related to higher tumor grade and metastasis in axillary lymph nodes.
resumo
abstract
Introdução: Estudos de vasos linfáticos eram limitados pela ausência de marcadores endoteliais linfáticos 
específicos. Recentemente, eles se tornaram possíveis após liberação comercial do novo anticorpo D2-40, 
marcador seletivo para endotélio linfático. O objetivo do nosso estudo foi comparar invasão neoplásica em vasos 
linfáticos e sanguíneos detectada em secções coradas pela hematoxilina e eosina (HE) e imuno-histoquímica 
(IIQ). Materiais e métodos: Foram estudados 123 casos de carcinomas mamários invasores subdivididos em três 
subgrupos de acordo com o estadiamento axilar: macrometástases (Mac-Met), micrometástases (Mic-Met) e 
linfonodo negativo (LNN). Invasão de vasos linfáticos (IVL) e de vasos sangüíneos (IVS) foi inicialmente avaliada 
em secções histológicas coradas pela HE e através da IIQ realizada em cortes seqüenciais. A invasão de vasos 
linfáticos e sanguíneos foi avaliada pela imuno-histoquímica, empregando-se respectivamente os anticorpos 
D2-40, e CD31. IVL e IVS foram relacionadas com tamanho tumoral, tipo e grau histológico dos tumores 
primários e com a presença de metástases. Resultados: IVL foi observada pela HE em 17/123 casos (13,8%) 
e pela IIQ em 35/123 casos (28,5%) (kappa = 0,433). IVS foi observada pela HE em 5/123 casos (4,1%) 
e pela IIQ em 19/123 casos (15,4%) (kappa = 0,198). IVL e IVS estavam positivamente relacionadas com 
maior grau histológico dos tumores primários (p < 0,05). IVL também estava positivamente relacionada com 
a presença de macrometástases. Conclusão: A detecção IIQ, respectivamente por D2-40 e CD31, de invasão 
de vasos linfáticos e sanguíneos foi maior que a detecção feita em cortes corados pela HE e relacionou-se com 
maior grau tumoral e metástases em linfonodos axilares.
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Introduction
The presence of lymph node metastasis represents a 
major criterion for evaluating the potential prognosis of 
breast cancer patients and predicts the choice of additional 
chemotherapy after surgery of primary tumor(19). Tumor-
associated lymphatic vessels are considered the main 
route of tumor cells to axillary lymph nodes. Lymphatic 
vessel invasion (LVI) by tumor cells is a prerequisite for 
dissemination via the lymphatic system(3, 19). Much is known 
about the formation of new blood vessels as a mechanism 
to support haematogenous spread and facilitate tumor 
growth. In contrast, little is known about the mechanisms 
involved in lymphatic spread(22).
LVI is known as an independent predictor of lymph node 
metastases in breast cancer. However, the identification of 
LVI can be difficult in hematoxylin and eosin (H&E) stained 
slides. Usually, LVI identification is based on conventional 
H&E staining, and the diagnosis is based on the presence 
of tumor emboli within vascular channels lined by a single 
layer of endothelial cells without red blood cells. Retraction 
artifacts that isolate tumor aggregates due to tissue 
shrinkage during fixation are sometimes confused with the 
true tumor emboli in lymphatic vessels(4, 23).
Several markers of blood vessel endothelium have 
been used including CD31, CD34, and factor VIII-related 
antigen (von Willebrand factor or vWF). However, studies 
of lymphatic vessels have been limited by lack of specific 
lymphatic endothelial markers and the immunohistochemical 
identification of lymphatic vessels has been unreliable(5, 19). 
Recently, novel selective markers for lymphatic endothelium 
have been released, such as LYVE-1, prox 1, and podoplanin(7). 
More recently, monoclonal antibody D2-40 was shown to 
selectively detect lymphatic vessels in breast and tonsillar 
tissue(13, 14). In these studies, endothelium of lymphatic vessels 
was immunoreactive to D2-40, while, in contrast, blood and 
lymphatic vessels endothelium was reactive to CD31, CD34, 
and vWF(5, 13, 14). D2-40 is an IgG2a monoclonal antibody 
generated against an oncofetal antigen M2A, which is 
normally expressed in the fetal testis and reexpressed in germ 
cell neoplasia(2). D2-40 stains the endothelium of lymphatic 
vessels and lymphangiomas. In contrast, hemangiomas, 
glomus tumors, angiolipomas, pyogenic granulomas, and 
vascular malformations did not show any staining(13, 14).
Studies of various tumors have shown the potential 
clinical significance of blood and lymphatic vessels, 
suggesting that blood and lymphatic microvessel density 
correlates with tumor growth and metastasis(5, 16).
The aim of our study is to compare lymphatic and blood 
vessel neoplastic invasion in invasive mammary carcinomas 
using H&E and immunohistochemical stained sections.
Material and methods
This study was conducted on 123 patients with 
invasive mammary carcinomas who had been submitted 
to surgical treatment (excisional biopsy, conservative 
breast surgery, and mastectomy) with axillary lymph 
node dissection at Hospital das Clínicas of Universidade 
Federal de Minas Gerais (UFMG), Brazil, between 1990 
and 2004. This research was approved by the Ethics 
Committee of the University. We selected 41 cases 
diagnosed as axillary lymph node negative (LNN), 41 
cases with micrometastases (Mic-Met [defined by The 
American Joint Committee on Cancer as neoplastic cell 
clusters measuring between 0.2 and 2 mm]), and 41 cases 
with macrometastases (Mac-Met [defined as neoplastic 
cell clusters larger than 2 mm])(12), based on the original 
histopathologic examination. No case of isolated tumor 
cells in lymph nodes was included in this study.
We initially selected the cases with micrometastases, and 
after this selection we matched the same number of cases 
with macrometastases and lymph node negative. Mean age 
of patients, histologic type and tumor grade of cases of each 
group were similar. For all cases, the original H&E-stained 
sections of primary tumors and axillary lymph nodes were 
available for histologic review. The paraffin blocks were 
available for additional sections and immunohistochemical 
analysis. Special care was taken to include only specimens 
with sufficient amount of normal tissue surrounding the 
invasive tumor to evaluate peritumoral lymphatic (LVI) and 
blood (BVI) vessel invasions.
Cases were evaluated considering age of patients and 
tumor size (using the TNM system)(12). Histologic analysis of 
primary breast carcinoma features included histologic type, 
histologic grade, and invasion of lymphatic and/or blood 
vessels. The histologic type of primary tumor was classified 
based on Page et al.(17) and the College of American Pathologists 
recommendations(10), using rigid criteria for classification 
of special types. Tumor grade was determined using the 
Nottingham grading system(8). The diameter of the microscopic 
field used for mitotic count was 0.44 mm. Lymphatic and/or 
blood vessel invasion was assessed by two pathologists (VFZM 
and HG), reviewing the H&E and immunohistochemical-
stained sections using a double-headed microscope.
H&E-stained sections of primary tumors were reviewed 
and new histologic sections were prepared for the 
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immunohistochemical study. Immunohistochemistry (IHC) 
was performed on 4 µm thickness sections, using monoclonal 
antibodies and the streptavidin-biotin peroxidase method. 
D2-40 (clone D2-40; Signet; 1:100) was used for lymphatic 
evaluation, and CD31 (clone JC/70A; Dako; 1:50), for 
blood and lymphatic vessel evaluation. CD31 sections were 
submitted to heat-induced epitope retrieval in citrate buffer 
pH6.0 for 25 minutes. Immunohistochemical reactions 
were developed with diaminobenzidine and sections were 
counterstained with Harrris hematoxylin. All immunostains 
were manually processed.
IHC using the monoclonal anti-cytokeratin antibody 
(clone AE1/AE3, Dako, USA) was also carried out on 
additional sections of all axillary lymph nodes initially 
classified as negative or with micrometastases.
The IHC-stained sections of all primary tumors and 
axillary lymph nodes were evaluated by the same pathologist 
without knowledge of axillary lymph node status. All lymph 
node positive, doubts, and 10% of negative lymph nodes, 
histologic type and grade of all primary tumors were re-
evaluated by two pathologists (VFZM and HG) using a 
double-headed microscope. Lymphatic and/or blood vessel 
invasion were considered evident if at least one tumor cell 
cluster was clearly visible in the vascular space. Vessels were 
considered lymphatic when the endothelium stained with 
both D2-40 and CD31 antibodies, without having red blood 
cells within the lumen. Small vessels were classified as blood 
vessels when the vascular endothelium stained only for the 
CD31 monoclonal antibody, was negative for D2-40, and 
presented red blood cells within the lumen.
Statistical analysis was performed using the Epi-info 
6.04b software. Kappa statistic test was used to compare 
blood and lymphatic neoplastic invasion in H&E and IHC 
stained sections.
Results
Patients' ages ranged from 27 to 88 years (mean = 
55.9 years and median = 52 years). Sixty-five out of 123 
patients (52.8%) were postmenopausal. Most tumors (65 
cases; 52.8%) were classified as T2 (2 to 5 cm), 38 cases 
(30.9%) measured between 1 and 2 cm, followed by tumors 
between 2 and 3 cm (29 cases; 23.6%) (Table	1).
Table 1
Clinicopathologic and immunohistochemical features of 123 cases of invasive mammary
carcinomas according to axillary lymph node status
Characteristics Mac-Met
n (%)
Mic-Met
n (%)
LNN
n (%)
Menopausal status
Premenopausal 20 (48.8) 18 (43.9) 20 (48.8)
Postmenopausal 21 (51.2) 23 (56.1) 21 (51.2)
Tumor size (TNM)
T1 10 (24.4) 17 (41.5) 17 (41.5)
T2 24 (58.5) 23 (56.1) 18 (43.9)
T3 7 (17.1) 1 (2.4) 6 (14.6)
Histologic type
Ductal NST 32 (78.1) 33 (80.4) 31 (75.6)
Special variants 3 (7.3) 4 (9.8) 3 (7.3)
Pure special type 6 (14.6) 4 (9.8) 7 (17.1)
Histologic grade
Low 9 (22) 14 (34.1) 13 (31.7)
Intermediate 21 (51.2) 18 (43.9) 19 (46.3)
High 11 (26.8) 9 (22) 9 (22)
LVI* (H&E) 12 (29.3) 3 (7.3) 2 (4.9)
BVI* (H&E) 2 (4.9) 1 (2.4) 2 (4.9)
LVI (IHC) 16 (39) 10 (24.4) 9 (22)
BVI (IHC) 6 (14.6) 11 (26.8) 2 (4.9)
Total 41 (100) 41 (100) 41 (100)
Mac-Met: macrometastases; Mic-Met: micrometastases; LNN: lymph node negative; n: number of cases; NST: non-special type; LVI: lymphatic vessel invasion; BVI: blood vessel 
invasion; H&E: hematoxylin and eosin; IHC: immunohistochemistry; *LVI detected by H&E was statistically related to histologic grade (p = 0.013) and BVI detected by H&E was 
related only to tumor size (p = 0.009).
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The most frequent histologic type of primary tumors 
was invasive ductal carcinoma non-special type (105 cases; 
85.4%), followed by special variants (10 cases; 8.1%), and 
pure special types (8 cases; 6.5%) (Table 1). The special 
types included four cases of invasive lobular, two cases 
of invasive tubular, one case of mucinous carcinoma and 
one case of apocrine carcinoma. The special variants were: 
lobular (two cases), tubular (three cases), mucinous (one 
case), apocrine (one case), micropapillary (two cases), 
mixed type micropapillary and mucinous (one case).
Intermediate histologic grade was the most common 
(58 cases; 47.2%), followed by low grade (36 cases; 29.3%), 
and high grade (29 cases; 23.6%) (Table 1).
Results of the LVI and BVI assessed by immunohistochemistry 
are summarized on Tables 1, 2	and 3.
LVI was found in H&E-stained slides in 17/123 cases 
(13.8%), while BVI was observed in 5/123 tumors (4.1%). 
LVI was detected in IHC-stained slides in 35/123 cases 
(28.5%), while BVI was identified in 19/123 tumors 
(15.4%). LVI and BVI were easier to identify in sections 
immunostained for D2-40 and CD31 than in the H&E-
stained sections (Tables 1 to 4) (Figure).
LVI was positively related to the presence of metastases 
(p = 0.002) and was more frequently found in the subgroup 
with macrometastases (12/17 cases). No relationship was 
observed between BVI and the presence of metastases 
(p = 0.81), except when BVI was detected by immunostained 
sections (p = 0.02). In these cases, BVI was more frequently 
found in the subgroup with micrometastases.
No relationship was observed between age of patients 
and LVI or BVI (p > 0.05). Similarly to age, no relationship 
was observed between LVI and histologic tumor type. LVI 
was more frequently seen in invasive ductal carcinoma of 
Table 4
Lymphatic and blood vessel invasion 
detected by hematoxylin and eosin 
and immunohistochemistry in 123 
invasive mammary carcinomas stratified 
according to axillary lymph node status: 
macrometastases, micrometastases and 
lymph node negative
Mac-Met Mic-Met LNN
n (%) n (%) n (%)
LVI (H&E) 12 (29.3) 3 (7.3) 2 (4.9)
LVI (IHC) 16 (39) 10 (24.4) 9 (22)
BVI (H&E) 2 (4.9) 1 (2.4) 2 (4.9)
BVI (IHC) 6 (14.6) 11 (26.8) 2 (4.9)
Total 41 (100) 41 (100) 41 (100)
Mac-Met: macrometastases; Mic-Met: micrometastases; LNN: lymph node negative; 
n: number of cases; LVI: lymphatic vessel invasion; BVI: blood vessel invasion; H&E: 
hematoxylin and eosin; IHC: immunohistochemistry.
Table 2
Lymphatic vessel invasion detected 
on hematoxylin and eosin and 
immunostained sections of 123 
invasive mammary carcinomas
LVI Immunohistochemistry
Positive Negative Total
H&E n (%) n (%) n (%)
Positive 14 (11.4) 3 (2.4) 17 (13.8)
Negative 21 (17.1) 85 (69.1) 106 (86.2)
Total 35 (28.5) 88 (71.5) 123 (100)
LVI: lymphatic vessel invasion; n: number of cases; Kappa value: 0.433; 95% confi-
dence interval: 0.229 to 0.636.
Table 3
Blood vessel invasion detected 
on hematoxylin and eosin and 
immunostained sections of 123 
invasive mammary carcinomas
BVI Immunohistochemistry
Positive Negative Total
H&E n (%) n (%) n (%)
Positive 3 (2.4) 2 (1.7) 5 (4.1)
Negative 16 (13) 102 (82.9) 118 (95.9)
Total 19 (15.4) 104 (84.6) 123 (100)
BVI: blood vessel invasion; n: number of cases; Kappa value: 0.198; 95% confidence 
interval: -0.144 to 0.541.
Figure	– A and B show lymphatic vessels containing tumor emboli with endothelium 
positive for D2-40 (arrow), adjacent to blood vessels with endothelium negative for 
D2-40 (double arrow) – 400x
non-special type. No relationship was detected between 
BVI and histologic tumor type (p > 0.05). BVI was positively 
related to tumor size (p = 0.009), and more frequently found 
in tumors greater than 2 cm. No relationship was observed 
between LVI and tumor size (p > 0.05).
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LVI was positively related to high-grade tumors both in 
H&E and IHC studies (p = 0.0006 and p = 0.04). BVI detected 
on H&E-stained slides was related to increase in tumor size 
(p = 0.009) and high-grade tumors (p = 0.009).
Discussion
In the present study, we used the novel lymphatic 
endothelial immunomarker D2-40 and the CD31 
antibody to identify lymphatic invasion in formalin-fixed 
paraffin-embedded breast carcinomas by performing 
immunohistochemistry.
D2-40 is considered a novel selective marker for 
endothelial lymphatic cells and does not react with 
endothelial cells of blood vessels(13). Our study confirmed 
that D2-40 selectively stains the endothelium of lymphatic 
vessels, which is covered with flattened endothelial 
cells without red blood cells in the lumen. Furthermore, 
immunoreactivity by D2-40 antibody was useful in 
detecting lymphatic vessels in sections from formalin-fixed 
and paraffin-embedded blocks. Our results showed that 
D2-40 is a reliable and useful tool to accurately diagnose 
lymphatic invasion in invasive breast cancer and they are 
in agreement with findings of other studies(1, 4, 16).
Our results demonstrated that tumor emboli, both in 
lymphatic and blood vessels, were easier to identify in the 
D2-40 and CD31 immunostained sections than in H&E-
stained slides. This is important for the differential diagnosis 
with tumor retraction artifacts. Isolated tumor aggregates 
due to tissue shrinkage during fixation are sometimes 
confused with true tumor emboli in lymphatic vessels(1, 4, 9, 
23). Because artifacts may occur at the tumor margin, some 
lymphatic neoplastic emboli that would be missed in the 
H&E-stained sections evaluation were more easily detected 
in the D2-40 stained sections. It has long been suggested 
that lymph vessel invasion, as a diagnostic reproducible 
feature, should only be considered outside tumor margin(13, 
22). Acs et al.(1) proposed that apparent retraction artifacts 
of the stroma from cells of invasive breast carcinoma on 
routine histologic sections are not a phenomenon merely 
due to inadequate fixation as currently believed. Rather, 
they probably signify biologic changes that alter tumor-
stromal interactions and contribute to lymphatic spread 
and tumor progression(1, 6, 18).
In our experience, the use of lymphatic endothelial 
markers should be considered the gold standard for 
lymph vascular invasion(11, 15, 21). They should be used in 
addition to H&E assessment of lymphatic invasion when 
studying LVI detection. The kappa score obtained in our 
study showed only moderate agreement regarding the 
lymphatic vessel invasion and poor agreement regarding 
blood vessel invasion, when compared to H&E-stained 
sections. The increased accuracy of LVI detection using 
immunohistochemistry for D2-40 and podoplanin was 
also demonstrated in other studies evaluating breast 
carcinomas(4, 6, 9, 18, 20) and other tumors such as melanomas 
and gastric cancer(11, 15, 21, 23).
In our study, the presence of lymphatic invasion 
detected in both H&E and IHC sections was associated 
with high histologic grade. Vleugel et al. also reported 
lymphatic vascular invasion associated with high tumor 
grade(22). Instead of being explained by retraction artifacts, 
as mentioned by Acs et al.(1), this correlation could be 
explained by the biologic properties of tumors with more 
aggressive features(19, 22). This could lead to the speculation 
that fast-growing and high-grade tumors produce more 
growth factors and offer a bigger clonal variety of tumor 
cells capable of invading lymphatic vessels compared with 
low-grade, slow-growing tumors(22). In our study, blood 
vessel invasion was related to tumor size in H&E-stained 
sections. A higher blood vessel formation is necessary 
during tumor growth(19), so the pathophysiology of tumor-
related blood vessels is different from that of lymphatic 
vessels. Capillaries are feeder vessels that ensure tissue 
viability, and promote growth and nutrition in malignant 
tumors. Lymphatic vessels, on the other hand, are draining 
vessels that are not essential for tumor metabolism and 
therefore would not provide any advantage for tumor 
growth or survival(2, 22).
To our knowledge, this is the first study that assessed 
lymphatic invasion in breast cancer evaluating cases 
stratified in subgroups according to axillary lymph node 
status (macrometastases, micrometastases, and lymph 
node negative). Lymphatic vessel invasion was positively 
related to status of axillary lymph nodes. The detection 
of lymphatic invasion was superior in IHC-stained sections 
than in H&E, in all subgroups. Lymphatic invasion detected 
by both H&E and IHC was superior in the subgroup with 
macrometastases (39% by IHC and 29.3% by H&E) 
compared with micrometastases or lymph node negative 
subgroup. Our results showed that lymphatic invasion 
detected by D2-40 staining could more reliably predict 
lymph node metastases than H&E-stained sections(1). In 
our study, the presence of lymphatic invasion related to 
axillary lymph node metastases and should be considered 
in patients selected for sentinel lymph node biopsy.
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In conclusion, our results confirm that D2-40 is a 
selective marker for lymphatic vessel endothelium and is 
a reliable and useful tool for identification of lymphatic 
tumor emboli in breast carcinomas. Immunohistochemistry 
for D2-40 is superior to H&E for lymph vascular neoplastic 
invasion identification. LVI is related to tumors with more 
aggressive features, indicating a potential for lymphatic 
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